As a high-tech enterprise, the company was founded in 1992 and has now become one of the leading enterprises in the in-vitro diagnosis industry in China controlled by central enterprises. It has been successively rated as “National Accredited Enterprise Technology Center”, “National Technological Innovation Demonstration Enterprise”, “National Intellectual Property Demonstration Enterprise”, “National Postdoctoral Research Workstation”, “Advanced Collective for Implementing the National Intellectual Property Strategy”, and has undertaken many national science and technology projects such as the “863 Plan” project and the “National International Science and Technology Cooperation Project”. The company's main business is R&D, production, marketing and service of medical testing instruments and supporting test strips. The company's products mainly include urine analysis, biochemical analysis, chemiluminescence immunoassay, gynecological discharge analysis, blood cell analysis, coagulation analysis, and integrated laboratories. Corporate honors: It has successively been rated as “National Enterprise Technology Center”, “National Technological Innovation Demonstration Enterprise”, and “Advanced Collective for Implementing the National Intellectual Property Strategy”, won the “National Famous Trademark”, “Jilin Provincial Quality Award”, and undertook many national and provincial science and technology projects, including “863 Plan Project”, “National Torch Program Project”, “National SME Innovation Fund Project”, “Provincial Double Ten Major Projects”, “Top 50 Medical Device Enterprises”, “2023 Changchun Top 100 Enterprises”, “2023 Changchun Top 100 Enterprises” “Top 20 Industrial Companies”, Changchun Non-Communist Party Building Five-Star Party Branch, etc.
No Data